TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

BITAC

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

BITAC

ST13

US500000098569862

Classe

1, 5, 9, 10, 42, 44

Pedido

98569862

Registro

7980562

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

38

Atualização mais recente

20/01/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 9, 10, 42, 44

Data de depósito

27/05/2024

Data de registro

14/10/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

14/10/2025

Última transação

20/01/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Código do desenho

4

Tipo de titular

27

Localização do titular

HEIDELBERG, DE

Examinador

KNIEF,MITCHELL IRVIN

Unidade examinadora

L30

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

VERAXA BIOTECH GMBH

Representantes

Michael J. Leonard Fox Rothschild LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 9Classe 10Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Antibodies and the chemical modifications and conjugates thereof for medical research purposes and medical laboratory tests for medical research purposes; Immunoglobulins for medical research use

Classe 5

antibodies and the chemical modifications and conjugates thereof for medical diagnosis and treatment purposes and medical laboratory tests for medical diagnosis and treatment purposes; immunoglobulins for medical use for the treatment and prevention of disease; vaccines; veterinary preparations, namely, anti- cancer medication, anti-inflammatory medication, anti-pain medication in cream, powder, tablet and injectable form; diagnostic preparations for medical use; therapeutic pharmaceutical preparations for medical use in the nature of anti-cancer medication, anti-inflammatory medication, and anti-pain medication in cream, powder, tablet and injectable form; pharmaceutical preparations, namely, anti-cancer preparations, anti-inflammatory preparations, and anti-pain preparations in cream, powder, tablet, and injectable form; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes and obesity in cream, powder, tablet, and injectable form

Classe 9

Opto-electronic apparatus and instruments, downloadable and recorded computer software, and microfluid bio chips for conducting antibody peptide or high-throughput active agent searches with small inorganic or organic molecules for scientific research purposes

Classe 10

Opto-electronic medical apparatus and instruments for conducting antibody peptide or high-throughput active agent searches with small inorganic or organic molecules for medical diagnosis and treatment purposes

Classe 42

scientific research conducted using high-throughput active agent searches and bioinformatics methods in the field of cancerous, inflammatory, autoimmune and metabolic diseases; drug discovery services; research and testing services in the field of antibody active agent identification for scientific research purposes; research, testing, and development services in the field of antibody modifications and conjugates identification for scientific research purposes; research and testing services in the field of vaccine development for scientific research purposes

Classe 44

medical services; medical diagnostic testing monitoring and reporting in the field of antibody active agents searches; medical screening services in the field of antibody active agents searches; medical screening services in the field of antibody active agents searches to determine antibody active agents originating from patients; personal medical information services provided via the internet

Publicações

Histórico de despachos e eventos da marca no USPTO.

38 publicações encontradas

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

19/01/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

19/01/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

19/01/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

19/01/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

19/01/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

14/10/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

14/10/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

26/08/2025

PUBO

PUBLISHED FOR OPPOSITION

26/08/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

20/08/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

23/07/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

23/07/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

23/07/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

23/07/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

23/07/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

21/07/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

21/07/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

21/07/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

30/05/2025

GNRT

NON-FINAL ACTION E-MAILED

30/05/2025

CNRT

NON-FINAL ACTION WRITTEN

30/05/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

30/04/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

30/04/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

30/04/2025

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

19/03/2025

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

19/03/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

19/12/2024

GNRT

NON-FINAL ACTION E-MAILED

19/12/2024

CNRT

NON-FINAL ACTION WRITTEN

19/12/2024

DOCK

ASSIGNED TO EXAMINER

10/12/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/12/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

13/11/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

13/11/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

13/11/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

13/11/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

13/11/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

13/11/2024

NWAP

NEW APPLICATION ENTERED

27/05/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace BITAC ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.